{"filing":{"accession_number":"0001193125-26-384426","cik":"0001090872","ticker":"A","company_name":"AGILENT TECHNOLOGIES, INC.","form":"8-K","filing_date":"2026-09-08","report_date":"2026-09-02","primary_document":"a-20260902.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1090872/000119312526384426/a-20260902.htm"},"events":[{"id":31828,"run_id":29227,"accession_number":"0001193125-26-384426","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"Glenn Boehnlein was appointed to the Board of Directors effective September 4, 2026, bringing significant financial and medical-technology sector expertise. Concurrently, Board Chair Boon Hwee Koh retired on the same date, and Dow R. Wilson was elected as the new Board chair.","company_name":"AGILENT TECHNOLOGIES, INC.","ticker":"A","filing_date":"2026-09-08","form":"8-K","submitted_at":null,"items":[{"id":34836,"accession_number":"0001193125-26-384426","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses two principal events: the retirement of Board Chair Boon Hwee Koh on September 4, 2026, and the appointment of Glenn Boehnlein to the Board on the same date. While both a departure and an appointment occur, the prose centers on filling the vacancy and introducing Boehnlein's qualifications, committee assignments, and compensation arrangements. Additionally, the supplemental press release emphasizes the appointment of Boehnlein and the election of Dow R. Wilson as the new Board chair, making the appointment the more salient disclosed action. Board-level appointments are material to investors assessing governance and oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T12:18:49.225622+00:00","company_name":"","ticker":null,"filing_date":""},{"id":34837,"accession_number":"0001193125-26-384426","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses two board-level events: the retirement of Board Chair Koh Boon Hwee (who served since 2003 and chaired the Executive Committee and Nominating and Corporate Governance Committee) and the appointment of Glenn Boehnlein to the board effective September 4, 2026. While both events are disclosed, the principal action emphasized in the press release is Boehnlein's appointment as a new director with significant financial and medical-technology sector expertise. The filing also notes Dow R. Wilson's election as the new board chair. The appointment of a new director with substantial CFO and board experience at a major medical-technology company is material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T12:18:49.225622+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34836,"accession_number":"0001193125-26-384426","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses two principal events: the retirement of Board Chair Boon Hwee Koh on September 4, 2026, and the appointment of Glenn Boehnlein to the Board on the same date. While both a departure and an appointment occur, the prose centers on filling the vacancy and introducing Boehnlein's qualifications, committee assignments, and compensation arrangements. Additionally, the supplemental press release emphasizes the appointment of Boehnlein and the election of Dow R. Wilson as the new Board chair, making the appointment the more salient disclosed action. Board-level appointments are material to investors assessing governance and oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T12:18:49.225622+00:00","company_name":"AGILENT TECHNOLOGIES, INC.","ticker":"A","filing_date":"2026-09-08"},{"id":34837,"accession_number":"0001193125-26-384426","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses two board-level events: the retirement of Board Chair Koh Boon Hwee (who served since 2003 and chaired the Executive Committee and Nominating and Corporate Governance Committee) and the appointment of Glenn Boehnlein to the board effective September 4, 2026. While both events are disclosed, the principal action emphasized in the press release is Boehnlein's appointment as a new director with significant financial and medical-technology sector expertise. The filing also notes Dow R. Wilson's election as the new board chair. The appointment of a new director with substantial CFO and board experience at a major medical-technology company is material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T12:18:49.225622+00:00","company_name":"AGILENT TECHNOLOGIES, INC.","ticker":"A","filing_date":"2026-09-08"}]}